Germline PRDM1 Variant rs2185379 in Long-Term Recurrence-Free Survivors of Advanced Ovarian Cancer

Germline PRDM1 Variant rs2185379 in Long-Term Recurrence-Free Survivors of Advanced Ovarian Cancer

Takashi Mitamura,1 Tianyue Zhai,1 Kanako C Hatanaka,2 Yutaka Hatanaka,2,3 Toraji Amano,4 Lei Wang,5,6 Shinya Tanaka,5,6 Hidemichi Watari1 1Department of Obstetrics and Gynecology, Hokkaido University Faculty of Medicine, Hokkaido University, Sapporo, Hokkaido, Japan; 2Center for Development of Advan...

Full description

Bibliographic Details
Main Authors: Mitamura T, Zhai T, Hatanaka KC, Hatanaka Y, Amano T, Wang L, Tanaka S, Watari H
Format: Article
Language:English
Published: Dove Medical Press 2022-11-01
Series:Pharmacogenomics and Personalized Medicine
Subjects:
ovarian cancer
long-term survivors
rs2185379
prdm1
Online Access:https://www.dovepress.com/germline-prdm1-variant-rs2185379-in-long-term-recurrence-free-survivor-peer-reviewed-fulltext-article-PGPM

Internet

https://www.dovepress.com/germline-prdm1-variant-rs2185379-in-long-term-recurrence-free-survivor-peer-reviewed-fulltext-article-PGPM

Similar Items